文献速递多重用药老年慢病共病管理老年综合评估

老年多病共存住院患者1年药物相关入院预测因素

Predictors of 1-year drug-related admissions in older multimorbid hospitalized adults.
PubMed 文献 · J Am Geriatr Soc · 2022-01-22

基于欧洲多中心OPERAM试验中1879例老年多病共存住院患者,评估易识别预测因素与1年内药物相关入院(DRA)的关联并构建预测评分。1年内435/1879(23.2%)患者发生DRA,评分含7个变量,C统计量为0.64(95%CI 0.61-0.67),校准良好但整体准确度有限。

要点

  • 既往住院、非择期入院、高血压、肝硬化伴门脉高压、慢性肾病、利尿剂、口服糖皮质激素为预测变量。
  • 评分<1分者DRA预测与观察风险均为12.4%,>3分者预测40.4%、观察38.9%。
  • 评分C统计量0.64(95%CI 0.61-0.67),区分度有限,需谨慎用于个体化筛查。

核心结论

  • 与药物代谢相关的共病、特定药物、非择期入院及既往住院史与更高的1年DRA风险相关,所建评分有助于识别最可能从预防干预中获益的患者。

研究设计与样本

  • 基于欧洲多中心OPERAM试验的1879例老年多病共存住院患者(平均年龄79.4岁),采用单变量逻辑回归筛选预测因素,再行后退法回归保留p<0.05变量构建评分,并通过十折交叉验证进行内部验证。

主要发现

  • 1年内435/1879(23.2%)患者发生DRA。
  • 评分纳入7个变量:既往住院、非择期入院、高血压、肝硬化伴门脉高压、慢性肾病、利尿剂、口服糖皮质激素。
  • C统计量为0.64(95%CI 0.61-0.67),校准显示预测与观察比例匹配良好,缩放Brier评分为0.05。
  • 评分<1分者DRA预测风险12.4%、观察风险12.4%;>3分者预测风险40.4%、观察风险38.9%。

关键数值与推荐

  • 预测变量筛选标准:单变量分析p<0.20进入后退回归,最终模型保留p<0.05的变量。
  • 模型区分度:C统计量0.64(95%CI 0.61-0.67)。
  • 整体准确度:缩放Brier评分0.05(<0.25提示模型有用)。
  • 风险分层:评分<1分者DRA风险12.4%,>3分者预测风险40.4%、观察风险38.9%。

临床怎么用

  • 对老年多病共存住院患者,可关注既往住院史、非择期入院、高血压、肝硬化伴门脉高压、慢性肾病及使用利尿剂或口服糖皮质激素者,识别DRA高风险人群以靶向预防干预。
  • 该评分区分度有限(C统计量0.64),不宜单独用于个体化风险预测,需结合临床判断。

局限性

  • 研究基于OPERAM试验人群,外部适用性需进一步验证。
  • 评分区分度有限(C统计量0.64),整体准确度指标缩放Brier评分为0.05。
  • 仅进行内部验证(十折交叉验证),未报告外部验证结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Identifying patients at high risk of drug-related hospital admission (DRA) may help to efficiently target preventive interventions. We developed a score to predict DRAs in older patients with multimorbidity and polypharmacy. METHODS: We used participants from the multicenter European OPERAM trial ("Optimising PharmacothERapy in the Mutlimorbid Elderly"). We assessed the association between easily identifiable predictors and 1-year DRAs by univariable logistic regression. Variables with p-value< 0.20 were taken forward to backward regression. We retained all variables with p < 0.05 in the model. We assessed the C-statistic, calibration (observed/predicted proportions), and overall accuracy (scaled Brier score, <0.25 indicating a useful model) of the score, and internally validated it by tenfold cross-validation. RESULTS: Within 1 year, 435/1879 (23.2%) patients (mean age 79.4 years) had a DRA. The score included seven variables: previous hospitalizations, non-elective admission, hypertension, cirrhosis with portal hypertension, chronic kidney disease, diuretic, oral corticosteroid. The C-statistic was 0.64 (95% CI 0.61-0.67). Patients with <1 point had a 12.4% predicted and observed risk of DRA, while those with >3 points had a 40.4% predicted and 38.9% observed risk of DRA. The scaled Brier score was 0.05. Calibration showed an adequate match between predicted and observed proportions. CONCLUSION: Comorbidities related to drug metabolism, specific medications, non-elective admission, and a history of hospitalization, were associated with a higher risk of DRA. Awareness of these associations and the score we developed may help identify patients most likely to benefit from preventive interventions.

来源:J Am Geriatr Soc,查看原文。版权归原作者所有。

引用

  1. Aubert CE, Rodondi N, Netzer S, et al. Predictors of 1-year drug-related admissions in older multimorbid hospitalized adults. J Am Geriatr Soc. 2022. PMID: 35064571. doi:10.1111/jgs.17667

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。